Skip to search boxSkip to navigationSkip to main content

Wilson's disease and the neuroleptic malignant syndrome

  • Peter Buckley(corresponding author)
    ,
  • Eamonn Carmody
    ,
  • Michael Hutchinson
*Corresponding author for this work
  • Mid-Western Regional Hospital Limerick
    ,
  • Royal College of Surgeons in Ireland
    ,
  • University College Dublin
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Wilson's Disease (Hepatolenticular degeneration) is an uncommon disorder of copper metabolism, characterised by excessive copper deposition in the liver, brain and eyes. Psychiatric symptoms were prominent in eight of the twelve patients originally described by Wilson some 88 years ago1. Since then a wide range of psychiatric presentations have been documented including behavioural disturbances, affective psychoses, schizophrenia-like psychoses, intellectual deterioration and dementia.2'3 Here we describe a patient who presented with a psychiatric disturbance, was treated with neuroleptic medication and subsequently developed Neuroleptic Malignant Syndrome (NMS).

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 138-139 (2 pages)

Journal (Volume, Issue Number)

Irish Journal of Psychological Medicine (Volume 7, Issue 2)

Publication milestones

  • Published - 09/1990

Publication status

Published - 09/1990

ISSN

0790-9667

Publication IDs

  • Scopus: 0025187585

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
7
Captures
6